MedTrace Logo

Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus

NCT02671162 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2016-02-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether Fumaria Parviflora L. can minimize severity of pruritus in patients with end-stage renal disease.

Conditions

Interventions

DRUG

Wheat

3 times a day each time 2 capsules before eating meal for 8 weeks.

DRUG

Fumaria

3 times a day each time 2 capsules before eating meal for 8 weeks.

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    lead OTHER

Principal Investigators

  • Jamshid Roozbeh, MD · Shiraz University of Medical Sciences

  • Pouya Faridi, PhD · Shiraz University of Medical Sciences

  • Rahimeh Akrami, PhD · Shiraz University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-10-31
Completion
2016-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671162 on ClinicalTrials.gov